Clinical trial
Jikei Optimal Insulin Therapy in Type 2 Diabetes
NCT00348231 · Jikei University School of Medicine, Other · Unknown status
Key facts
| NCT number | NCT00348231 |
|---|---|
| Title | Jikei Optimal Insulin Therapy in Type 2 Diabetes |
| Lead sponsor | Jikei University School of Medicine, Other |
| Collaborators | Novo Nordisk A/S Industry |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | dual-action insulin analog |
| Enrollment | 60 |
| Start date | Nov 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Jul 4, 2006 |
| Last update posted | Sep 1, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: